Revvity Reports Preliminary Revenue For The Fourth Quarter Of At Least $690M, Resulting In A Reported And Non-covid Organic Revenue Decline Of Approximately -7% And -4% As Compared To The Same Period A Year Ago, Respectively
Portfolio Pulse from Benzinga Newsdesk
Revvity (RVTY) reported preliminary Q4 revenue of at least $690M, indicating a -7% reported revenue decline and a -4% non-COVID organic revenue decline year-over-year.
January 09, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Revvity's preliminary Q4 revenue of $690M reflects a -7% reported and -4% non-COVID organic decline compared to the previous year.
The reported decline in both reported and non-COVID organic revenue for Revvity is likely to negatively impact investor sentiment in the short term, as revenue is a key indicator of a company's financial health and growth prospects.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100